Solvent-Free C-3 Coupling of Azaindoles with Cyclic Imines by Belasri, Khadija et al.
molecules
Article
Solvent-Free C-3 Coupling of Azaindoles with
Cyclic Imines
Khadija Belasri 1,2, Ferenc Fülöp 1,2 and István Szatmári 1,2,*
1 Institute of Pharmaceutical Chemistry and MTA-SZTE Stereochemistry Research Group, University of
Szeged, H-6720 Szeged, Hungary; Khadija.belasri@pharm.u-szeged.hu (K.B.);
fulop@pharm.u-szeged.hu (F.F.)
2 Institute of Pharmaceutical Chemistry, Interdisciplinary Centre of Excellence, University of Szeged,
H-6720 Szeged, Hungary
* Correspondence: szatmari.istvan@pharm.u-szeged.hu
Academic Editor: Antal Csámpai
Received: 3 September 2019; Accepted: 2 October 2019; Published: 4 October 2019


Abstract: By direct coupling 7-azaindole and cyclic imines, such as 3,4-dihydroisoquinoline,
6,7-dihydrothieno[3,2-c]pyridine, 3,4-dihydro-β-carboline, and 4,5-dihydro-3H-benz[c]azepine,
new 3-substituted 7-azaindole derivatives have been synthesized. The reaction was extended
to 4-azaindoles and 6-azaindoles, as electron-rich aromatic compounds. The lowest reactivity was
observed in the case of C-3 substitution of 5-azaindole. In this case, the aza-Friedel-Crafts reaction
took place by using 10 mol % of p-toluenesulfonic acid (p-TSA) as the catalyst. The role of the
acid catalyst can be explained by the different pKa values of the azaindoles. All reactions were
performed in solvent-free conditions by using both classical heating and microwave irradiation.
In all cases, microwave heating proved to be more convenient to synthesize new C-3-substituted
azaindole derivatives.
Keywords: cyclic imines; 7-azaindole; 6-azaindole; 4-azaindole; 5-azaindole; aza-Friedel-Crafts
reaction; microwave reaction
1. Introduction
7-Azaindole is a well-known hinge-binding element in kinase inhibition [1–5]. The N atom of
the pyridine ring and the NH group of the pyrrole moiety of 7-azaindole serve as the hydrogen bond
acceptor and donor, respectively, to make bidentate hydrogen bonds with the hinge region of the kinase.
7-Azaindole has five modification sites where various substituents can be readily attached to obtain
7-azaindole derivatives with improved activity. Among them, vemurafenib [6], a B-RAF kinase (serine
–threonine kinase (STK)) inhibitor, is the first U.S. Food and Drug Administration (FDA)-approved,
7-azaindole-based kinase drug for the treatment of melanoma [7]. Vemurafenib was discovered through
lead optimization, starting from a small 7-azaindole fragment, and now it is recognized as the first
successful example of a “fragment-based” drug discovery approach [8]. Some derivatives have been
developed that target various kinds of kinases, including Janus kinase 3 (JAK3; a cytoplasmic tyrosine
kinase (TK)) [9]; colony stimulating factor 1 receptor (CSF1R; a TK receptor) [10]; aurora kinases
(STKs) [11]; and Rho-associated, coiled coil-containing protein kinase 1 (ROCK1; STK) [12].
Thanks to the close similarity of azaindoles to the indole skeleton, C-3 functionalization of these
compounds has been postulated [13,14]. Most of the methods known already for the synthesis of
3-functionalized 7-azaindole derivatives have applied multistep transformations. Particular efforts have
been made to insert another biologically active moiety, such as tetrahydroisoquinoline, into position
three. In this case, the synthesis of 1-(7-azaindol-3-yl)-1,2,3,4-tetrahydroisoquinoline involves the
coupling of 7-azaindole with N-protected tetrahydroisoquinoline under iron and copper catalysis [15,16].
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The catalyst-free direct coupling of partially-saturated cyclic amines and indole as an electron-rich
aromatic compound, via a modified aza-Friedel-Crafts reaction, has recently been published by our
research group [17,18]. The reaction has been extended by using indole-2-carboxylic acid as a substrate,
leading to the formation of γ-amino acid derivatives [17].
Our aim was to perform a systematic study of the synthesis of azaindole derivatives (7-,
4-, 5-, and 6-azaindoles), applying the modified aza-Friedel–Crafts reaction using cyclic imine
substrates, such as 3,4-dihydroisoquinoline; 6,7-dihydrothieno[3,2-c]pyridine; 3,4-dihydro-β-carboline;
and 4,5-dihydro-3H-benz[c]azepine.
2. Results
In our initial experiments, 7-azaindole (compound 1) was reacted with 1.5 equivalent of
3,4-dihydroisoquinoline (compound 2), which was synthesized using a method from the literature
(Scheme 1) [18]. The reaction between compounds 1 and 2 was performed in solvent-free conditions
by classical heating (oil bath) at 60 ◦C (i). Based on thin-layer chromatography (TLC), the reaction over
a time of 18 h resulted in the formation of a multi-spot reaction mixture; the desired product (compound
3) was isolated by chromatography, with a yield of 31%. Since the yield was not satisfactory, the reaction
was repeated at 80 ◦C (ii). A 10 h reaction led to the formation of compound 3, with a yield of 49%.
Despite increasing the temperature further (100 ◦C, (iii)), the relatively long reaction led to compound
3 only with a poor yield (28%). When the reaction was repeated under microwave irradiation by
testing three different reaction conditions (Table 1), 3-(1,2,3,4-tetrahydroisoquinolin-1-yl)-7-azaindole
(3) was isolated with a yield of 81% after 120 min at 100 ◦C (Table 1). It is interesting to note that for
microwave reactions, 2 equivalents of 3,4-dihydroisoquinoline was applied to provide homogeneity
for the reaction mixture.
Scheme 1. Synthesis of 7-azaindole derivatives, starting from different cyclic imines.
Table 1. Reaction conditions for the synthesis of the azaindole compounds 3 and 7–9.
Products Reaction Time a Temperature a Yield a(%) Reaction Time b Temperature b Yield b (%)
3
18 h
10 h
6 h
60 ◦C (i)
80 ◦C (ii)
100 ◦C (iii)
31
49
28
2 h
4 h
2 h
80 ◦C (ii)
80 ◦C (ii)
100 ◦C (iii)
55
63
81
7 10 h 80 ◦C (ii) 56 2.5 h 100 ◦C (iii) 75
8 6 h 80 ◦C (ii) 76 2 h 100 ◦C (iii) 89
9 20 h 80 ◦C (ii) 63 3 h 100 ◦C (iii) 78
a classical heating, b microwave irradiation.
The reaction was extended by using other cyclic imines, such as 3,4-dihydro-β-carboline
(compound 4) [19]; 6,7-dihydrothieno[3,2-c]pyridine (compound 5) [20]; and 4,5-dihydro-3H-
benz[c]azepine (compound 6) [21,22]. Reactions were performed by using both oil-bath heating
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and microwave irradiation (Scheme 1). Table 1 shows that the corresponding products—compounds 7,
8, and 9—were isolated in higher yields when microwave conditions were applied. It can be concluded
that 6,7-dihydrothieno[3,2-c]pyridine (5) was found to be the most reactive cyclic imine. Yields and the
applied reaction conditions are summarized in Table 1.
With the optimal reaction conditions in hand, we focused on extending the series of electron-rich
aromatic compounds in a modified aza-Friedel-Crafts reaction. Accordingly, 4-azaindole (compound
10) and 6-azaindole (compound 11) were also reacted with cyclic imines 2, 4, 5, and 6 (Scheme 2).
Scheme 2. The extension of a modified aza-Friedel–Crafts reaction, starting from 4-azaindole
and 6-azaindole.
Reactions were performed under solvent-free conditions by both classical heating and using
microwave irradiation. The new azaindole derivatives, formed in reaction times indicated in Table 2,
were isolated and purified by crystallization or column chromatography (see Material and Methods).
It can be concluded that the use of microwave irradiation afforded the desired products (compounds
12–19) in higher yields and with significantly shorter reactions, compared with those using oil-bath
heating (Table 2).
Table 2. Reaction conditions for the synthesis of the azaindoles 12–19.
Products Reaction Time a Temperature a Yield a (%) Reaction Time b Temperature b Yield b (%)
12 20 h 80 ◦C (ii) 49 2.5 h 100 ◦C (iii) 70
13 22 h 80 ◦C (ii) 39 2.5 h 100 ◦C (iii) 65
14 16 h 80 ◦C (ii) 52 2.5 h 100 ◦C (iii) 69
15 20 h 80 ◦C (ii) 48 2.5 h 100 ◦C (iii) 62
16 7 h 80 ◦C (ii) 63 2.5 h 100 ◦C (iii) 85
17 8 h 80 ◦C (ii) 62 2.5 h 100 ◦C (iii) 75
18 21 h 80 ◦C (ii) 57 3 h 100 ◦C (ii) 68
19 25 h 80 ◦C (ii) 55 3 h 100 ◦C (iii) 64
a classical heating, b microwave irradiation.
Since the catalyst-free coupling of 7-, 6-, and 4-azaindoles resulted in the desired C-3 aminoalkylated
derivatives, we focused our attention on the aza-Friedel-Crafts reaction of 5-azaindole (compound 20).
In our first experiment, 20 was reacted with 3,4-dihydroisoquinoline (2) as representative cyclic imine
(Scheme 3). However, even when applying different reaction conditions (classical heating, microwave
irradiation) and different temperatures (80 ◦C (ii), 100 ◦C (iii), 120 ◦C (iv)), target compound 21 did
not form. There was no conversion at lower temperature (80 ◦C, 100 ◦C), while higher temperature
(120 ◦C) resulted in the formation of a multi-spot reaction mixture. Since p-toluenesulfonic acid
(p-TSA) is a frequently applied acid catalyst in the modified three-component Mannich reaction [23–25],
we decided to examine its effect on the reaction between 20 and 3,4-dihydroisoquinoline. First,
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10 mol % of p-TSA was tested by using oil-bath conditions. In this case, TLC showed the formation
of a new compound, which after isolation (30%) proved to be the desired 5-azaindole derivative
21. Since the reaction needed a relatively long reaction time (19 h) and resulted in a poor yield,
it was repeated by using microwave irradiation. In this case, 100 ◦C proved to be optimal,
and 3-(1,2,3,4-tetrahydroisoquinolin-1-yl)-5-azaindole (21) was isolated with a yield of 72% (Table 3).
Scheme 3. Synthesis of compounds 21–24 from 5-azaindole.
Table 3. Reaction conditions for the synthesis of the products 21–24.
Products Reaction Time a Temperature a Yield a (%) Reaction Time b Temperature b Yield b (%)
21
24 h
21 h
8 h
19 h c
80 ◦C (ii)
100 ◦C (iii)
120 ◦C (iv)
80 ◦C (ii)
-
-
-
30
2.5 h
2.5 h
2 h
2.5 h c
80 ◦C (ii)
100 ◦C (iii)
120 ◦C (iv)
100 ◦C (iii)
-
-
-
72
22 15 h c 80 ◦C (ii) 44 2 h c 100 ◦C (iii) 69
23 7 h c 80 ◦C (ii) 62 2 h c 100 ◦C (iii) 80
24 15 h c 80 ◦C (ii) 52 3.5 h c 100 ◦C (iii) 65
a classical heating, b microwave irradiation, c p-TSA.
By applying 10 mol % of p-TSA catalyst, C-3 aminoalkylation of 5-azaindole was extended
with additional cyclic imines, such as 6,7-dihydrothieno[3,2-c]pyridine; 3,4-dihydro-β-carboline;
and 4,5-dihydro-3H-benz[c]azepine (Scheme 3). Reaction conditions and yields are summarized in
Table 3. As the data show, there is a difference between the reactivity of 7-, 6-, and 4-azaindoles
and that of 5-azaindole—that is, for C-3 aminoalkylation of 5-azaindole an acid catalyst was needed.
The lower reactivity of 5-azaindole can be accounted for by its higher pKa value (8.42), compared
with those of 6-azaindole (5.61), 4-azaindole (4.85), and 7-azaindole (3.67). The given pKa values were
calculated by using the Marvin Sketch software (version 16.12.12.0, calculation module developed
by ChemAxon) [26]. The pKa values of azaindoles depend on the resonance stabilization of their
protonated forms. The reason why the aza-Friedel-Crafts reaction of 5-azaindole occurs only under
acidic conditions is that 5-azaindole has the highest basicity in the series of 4-, 5, 6-, and 7-azaindoles.
It is interesting to note that the fastest reactions were achieved with the electron-rich aromatic compound
7-azaindole. This is in complete agreement with its calculated pKa value (3.67), indicating that it is the
most acidic compound among the azaindoles studied.
3. Materials and Methods
3.1. General Methods
Melting points were determined on a Hinotek X-4 (Hinotek Technology Co., Ltd., Ningbo, China)
melting point apparatus. Elemental analyses were performed with a Perkin-Elmer 2400 CHNS
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elemental analyzer (Perkin-Elmer, Waltham, MA, USA) in the Institute of Pharmaceutical Chemistry,
University of Szeged. Merck Kieselgel 60F254 plates (Merck Hungary, Budapest, Hungary) were used
for the TLC. The microwave reactions were performed with a CEM Discover SP microwave reactor
(CEM, Matthwes, NC, USA).
The starting cyclic imines 3,4-dihydroisoquinoline (2) [18]; 3,4-dihydro-β-carboline (4) [19];
6,7-dihydrothieno[3,2-c]pyridine (5) [20]; and 4,5-dihydro-3H-benz[c]azepine (6) [21,22] were
synthesized according to the literature.
The 1H-and 13C-NMR spectra were recorded in CDCl3 or [D6]DMSO solution in 5 mm tubes at
room temperature, on a Bruker Avance II spectrometer (Bruker, Karlsruhe, Germany) at 500 (1H) and
125 (13C) MHz, with the deuterium signal of the solvent as the lock and TMS as the internal standard.
All spectra (1H, 13C) were acquired and processed with the standard BRUKER software.
Procedures
For method A, the cyclic imine 3,4-dihydroisoquinoline (66 mg, 0.50 mmol);
6,7-dihydrothieno[3,2-c]pyridine (51 mg, 0.38 mmol); 3,4-dihydro-β-carboline (63 mg, 0.38 mmol) or
4,5-dihydro-3H-benz[c]azepine (55 mg, 0.38 mmol); and the azaindoles (7-, 6- or 4-azaindole, (30 mg,
0.25 mmol)) were mixed in a 25 mL round bottom flask. The mixture was heated in an oil bath.
Reaction conditions are shown in Tables 1–3. In the case of 5-azaindole, 10 mol % (4.3 mg, 0.025 mmol)
of p-TSA as a catalyst was also added.
For method B, the mixture of the cyclic imine 3,4-dihydroisoquinoline (66 mg, 0.50 mmol);
6,7-dihydrothieno[3,2-c]pyridine (51 mg, 0.38 mmol); 3,4-dihydro-β-carboline (63 mg, 0.38 mmol) or
4,5-dihydro-3H-benz[c]azepine (55.3 mg, 0.38 mmol); and the electron-rich aromatic compound (7-, 6-,
4-, or 5-azaindole (30 mg, 0.25 mmol)) were placed in a 10 mL pressurized reaction vial and heated in
a microwave reactor, under the conditions given in Tables 1–3. In the case of 5-azaindole, 10 mol % of
p-TSA (4.3 mg, 0.025 mmol) as a catalyst was also added.
3.2. Synthesis of New Compounds
3.2.1. Synthesis of 3-(1,2,3,4-Tetrahydroisoquinolin-1-yl)-7-azaindole
Compound 3 (Figures S1 and S2) was crystallized from Et2O, recrystallized from i-Pr2O. It was
a white solid, with mp: 178–180 ◦C (Lit.: [16] mp: 172–174◦C); yield: 81% (51 mg); 1H-NMR ([D6]
DMSO): δ = 2.73–2.81 (1H, m), 2.91–3.00 (2H, m), 3.10–3.17 (1H, m), 5.29 (1H, s), 6.79 (1H, d, J = 7.9 Hz),
6.87 (1H, t, J = 7.6 Hz), 6.88–6.93 (1H, m), 6.97 (1H, t, J = 5.2 Hz), 7.07–7.16 (2H, m), 7.24 (1H, s), 7.65 (1H,
d, J = 7.7 Hz), 8.14 (1H, d, J = 5.1 Hz), and 11.40 (1H, s); 13C-NMR ([D6]DMSO): δ = 29.7, 42.3, 54.5,
115.3, 117.5, 118.9, 125.3, 125.8, 126.3, 127.6, 128.6, 129.3, 135.6, 139.2, 142.9, and 149.4. The analysis
calculated for C16H15N3 found C: 77.08; H: 6.06; and N: 16.85; found values were C: 77.10; H: 5.98,
and N: 16.88.
3.2.2. Synthesis of 3-(1,2,3,4-Tetrahydro-β-carboline-1-yl)-7-azaindole
Product 7 (Figures S3 and S4) was crystallized from Et2O and recrystallized from i-Pr2O. It was
a white solid, with mp: 219–220 ◦C; yield: 75% (55 mg); 1H-NMR ([D6]DMSO): δ = 2.64–2.73 (1H,
m), 2.75–2.84 (1H, m), 2.93–3.01 (1H, m), 3.13–3.21 (1H, m), 5.38 (1H, s), 6.87–7.00 (3H, m), 7.15 (1H,
d, J = 7.8 Hz), 7.30 (1H, s), 7.42 (1H, d, J = 7.6 Hz), 7.63 (1H, d, J = 8.4 Hz), 8.14 (1H, d, J = 4.4 Hz),
10.38 (1H, s,), and 11.50 (1H, s, brs); 13C-NMR ([D6]DMSO): δ = 22.0, 42.1, 49.7, 107.4, 107.9, 111.6,
118.1, 118.8, 121.3, 123.8, 126.6, 127.2, 135.0, 136.4, 140.3, 140.4, and 143.1. The analysis calculated for
C18H16N4 found C: 74.98, H: 5.59, and N: 19.43; the found values were C: 74.91, H: 5.60, and N: 19.45.
3.2.3. Synthesis of 3-(4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-4-yl)-7-azaindole
Product 8 (Figures S5 and S6) was crystallized from Et2O and recrystallized from i-Pr2O. It was
a white solid, with mp: 191–195 ◦C; yield: 89% (58 mg); 1H-NMR ([D6]DMSO): δ = 2.74–2.81 (1H, m),
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2.85–3.01 (2H, m), 3.12–3.20 (1H, m), 5.25 (1H, s), 6.49 (1H, d, J = 6.1 Hz), 6.92–6.98 (1H, m), 7.14 (1H, d,
J = 5.3 Hz), 7.20–7.24 (1H, m), 7.71 (1H, d, J = 9.6 Hz), 8.15 (1H, d, J =7.2 Hz), 7.42 (1H, d, J = 7.9 Hz),
and 11.14 (1H, s,); 13C-NMR (CDCl3): δ = 26.1, 42.2, 52.3, 115.8, 117.0, 119.0, 121.8, 123.8, 126.4, 128.2,
134.7, 136.6, 143.0, and 149.1 The analysis calculated for C14H13N3S was C: 65.85, H: 5.13, and N: 16.46;
found values were C: 65.83, H: 5.15, and N: 16.50.
3.2.4. Synthesis of 3-(2,3,4,5-Tetrahydro-1H-benz[c]azepin-1-yl)-7-azaindole
Product 9 (Figures S7 and S8)was crystallized from Et2O and recrystallized from i-Pr2O. It was
a white solid, with mp: 192–194 ◦C; yield: 78% (52 mg); 1H-NMR ([D6]DMSO): δ = 2.87–2.96 (1H, m),
2.97–3.14 (3H, m), 3.30 (2H, s), 5.40 (1H, s), 6.80 (1H, d, J = 8.1 Hz), 6.95–7.07 (3H, m), 7.11 (1H, t, J = 7.2
Hz), 7.19 (1H, d, J = 7.4 Hz), 7.84 (1H, d, J = 8.4 Hz), 8.19 (1H, d, J = 5.5 Hz), and 11.45 (1H, s); 13C-NMR
([D6]DMSO): δ = 29.9, 35.5, 49.6, 59.7, 115.2, 115.5, 119.1, 124.5, 126.1, 127.1, 128.0, 128.6, 130.1, 142.5,
143.0, 144.8, 149.8, The analysis calculated for C17H17N3 was C: 77.54, H: 6.51, and N: 15.96; found
values were C: 77.60, H: 6.52, and N: 15.98.
3.2.5. Synthesis of 3-(1,2,3,4-Tetrahydroisoquinolin-1-yl)-4-azaindole
Product 12 (Figures S9 and S10) was crystallized from Et2O and recrystallized from i-Pr2O. It was
a light beige solid, with mp: 166–168 ◦C; yield: 70% (44 mg); 1H-NMR ([D6]DMSO): δ = 2.74–2.84 (1H,
m), 2.85–2.93 (2H, m), 3.04–3.11 (1H, m), 5.50 (1H, s), 6.94–7.02 (2H, m), 7.06–7.15 (4H, m), 7.74 (1H, d,
J = 8.1 Hz), 8.32 (1H, d, J = 4.6 Hz), and 11.12 (1H, s); 13C-NMR ([D6]DMSO): δ = 29.7, 41.4, 52.6, 116.8,
119.0, 119.4, 125.6, 126.2, 127.8, 127.9, 129.2, 129.3, 135.6, 139.6, 142.3, and 144.9; The analysis calculated
for C16H15N3 was C: 77.08, H: 6.06, and N: 16.85; found values were C: 77.09, H: 5.99, and N: 16.89.
3.2.6. Synthesis of 3-(1,2,3,4-Tetrahydroisoquinolin-1-yl)-6-azaindole
Product 13 (Figures S11 and S12) was purified by column chromatography
(Dichloro-methane(DCM)/MeOH 9:1) and crystallized from n-hexane. It was a light beige
solid, with mp: 152–154 ◦C; yield: 65% (41 mg); 1H-NMR ([D6]DMSO): δ = 2.72–2.79 (1H, m), 2.89–2.98
(2H, m), 3.08–3.14 (1H, m), 5.29 (1H, s), 6.76 (1H, d, J = 8.1 Hz), 6.96 (1H, t, J = 5.6 Hz), 7.05–7.15 (2H,
m), 7.25 (1H, d, J = 7.5 Hz), 7.36 (1H,s), 7.94 (1H, d, J = 6.1 Hz), 8.68 (1H, s), and 11.36 (1H, s); 13C-NMR
([D6]DMSO): δ = 29.8, 42.4, 54.01, 115.0, 118.8, 125.8, 126.3, 127.5, 128.7, 129.3, 130.9, 134.3, 134.8, 135.7,
137.5, and 139.5 The analysis calculated for C16H15N3 was C: 77.08, H: 6.06, and N: 16.85; found values
were C: 77.12, H: 5.98, and N: 16.87.
3.2.7. Synthesis of 3-(1,2,3,4-Tetrahydro-β-carboline-1-yl)-4-azaindole
Product 14 (Figures S13 and S14) was crystallized from Et2O, recrystallized from i-Pr2O. It was
a light brown solid, with mp: 157–160 ◦C; yield: 69% (50 mg); 1H-NMR (500 MHz, ([D6]DMSO): δ =
2.86–3.06 (2H, m); 3.37–3.54 (1H, m), 6.04 (1H, s), 6.94–7.09 (2H, m), 7.14–7.29 (2H, m), 7.43–7.58 (2H,
m), 7.85 (1H, d, J =8.6 Hz), 8.34–8.45 (1H, m), 10.81 (1H, s,), and 11.60 (1H, s, brs). 13C-NMR (CDCl3): δ
= 22.4, 42.1, 49.0, 107.78, 111.4, 117.1, 118.0, 118.9, 119.0, 121.3, 125.6, 127.2, 129.6, 135.4, 135.6, 142.6,
143.0, and 144.0. The analysis calculated for C18H16N4 was C: 74.98, H: 5.59, and N: 19.43; found values
were C: 74.97, H: 5.62, N: 19.43.
3.2.8. Synthesis of 3-(1,2,3,4-Tetrahydro-β-carboline-1-yl)-6-azaindole
Product 15 (Figures S15 and S16) was purified by column chromatography (DCM/MeOH 3:1) and
crystallized from n-hexane. It was a light brown solid, with mp: 217–219 ◦C; yield: 62% (45 mg); 1H-NMR
([D6]DMSO): δ = 2.65–2.84 (2H, m), 2.93–3.02 (1H, m), 3.11–3.19 (1H, m), 6.92–6.99 (2H, m), 5.43 (1H, s), 7.18
(1H, d, J =7.6 Hz), 7.24(1H, d, J = 5.4 Hz), 7.38–4.44 (1H, m), 7.94 (1H, d, J = 5.6 Hz), 8.70 (1H, s), 10.37 (1H,
s,), and 11.44 (1H, s, brs); 13C-NMR ([D6]DMSO): δ = 22.6, 42.4, 49.8, 108.4, 111.52, 114.62, 118.02, 118.60,
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120.8, 127.3, 128.9, 131.1, 134.3, 134.9, 136.0, 136.2, and 137.7. The analysis calculated for C18H16N4 was C:
74.98, H: 5.59, and N: 19.43; found values were C: 74.96, H: 5.61, and N: 19.44.
3.2.9. Synthesis of 3-(4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-4-yl)-4-azaindole
Product 16 (Figures S17 and S18) was crystallized from Et2O and recrystallized from i-Pr2O. It was
a white solid, with mp: 179–182 ◦C; yield: 85% (55 mg); 1H-NMR ([D6]DMSO): δ = 2.73–2.82 (2H, m),
2.90–2.98 (1H, m), 3.11–3.15 (1H, m), 5.25 (1H, s), 6.50 (1H, d, J = 4.9 Hz), 6.91 (1H, t, J = 7.4 Hz), 7.05
(1H, t, J = 7.6 Hz), 7.07 (1H, s), 7.13 (1H, d, J = 5.1 Hz), 7.34 (1H, t, J = 7.9 Hz), 7.42 (1H, d, J = 7.9 Hz),
10.85 (1H, s), 8.19 (1H, s, brs), 11.52 (1H, s,), and 16.78 (1H, s, brs); 13C-NMR (CDCl3): δ = 25.6, 41.3,
50.6, 117.1, 118.0, 118.5, 121.9, 126.3, 126.7, 129.3, 134.7, 135.8, 143.0, and 144.4. The analysis calculated
for C14H13N3S was C: 65.85, H: 5.13, N: 16.46; found values were C: 65.82, H: 5.12, and N: 16.48.
3.2.10. Synthesis of 3-(4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-4-yl)-6-azaindole
Product 17 (Figures S19 and S20) was purified by column chromatography (DCM/MeOH 9:1) and
crystallized from n-hexane. It was a white solid, with mp: 167–169 ◦C; yield: 75% (49 mg); 1H-NMR
([D6]DMSO): δ = 2.71–2.80 (1H, m), 2.82–2.99 (2H, m), 3.09–3.16 (1H, m), 5.23 (1H, s), 6.46 (1H, d,
J = 5.1 Hz), 7.13 (1H, d, J =5.6 Hz), 7.25–7.40 (2H, m), 7.98 (1H, d, J = 5.4 Hz), 8.68 (1H, s), and 11.35
(1H, s); 13C-NMR (CDCl3): δ = 26.0, 42.2, 51.8, 114.2, 118.3, 122.0, 126.1, 127.4, 131.3, 133.8, 134.1, 134.8,
136.4, and 138.2. The analysis calculated for C14H13N3S was C: 65.85, H: 5.13, and N: 16.46; found
values were C: 65.83, H: 5.15, and N: 16.45.
3.2.11. Synthesis of 3-(2,3,4,5-Tetrahydro-1H-benzo[c]azepin-1-yl)-4-azaindole
Product 18 (Figures S21 and S22) was crystallized from Et2O and recrystallized from i-Pr2O. It was
a light beige solid, with mp: 162–165 ◦C; yield: 68% (45 mg); 1H-NMR (500 MHz, ([D6]DMSO): δ =
2.95–3.03 (1H, m), 3.18–3.29 (3H, m), 3.30–3.40 (2H, m), 6.06 (1H, s), 6.85 (1H, d, J = 7.4 Hz), 7.06 (1H, t,
J = 7.9 Hz), 7.18–7.25 (2H, m), 7.29 (1H, d, J = 7.4 Hz), 7.60 (1H, s), 7.90 (1H, d, J = 8.4 Hz), 8.35 (1H, d, J
= 4.6 Hz), and 11.76 (1H, s); 13C-NMR (100 MHz, [D6]DMSO): δ = 25.9, 34.0, 49.4, 57.5, 111.4, 117.6,
119.8, 126.6, 128.7, 128.8, 129.3, 129.4, 130.0, 138.0, 142.5, 142.9, and 144.1. The analysis calculated for
C17H17N3 was C: 77.54, H: 6.51, and N: 15.96; found values were C: 77.53, H: 6.53, and N: 15.99.
3.2.12. Synthesis of 3-(2,3,4,5-Tetrahydro-1H-benzo[c]azepin-1-yl)-6-azaindole
Product 19 (Figures S23 and S24) was purified by column chromatography (DCM/MeOH 9:1)
and crystallized from n-hexane. It was a light beige solid, with mp: 154–156 ◦C; yield: 64% (42 mg);
1H-NMR (500 MHz, ([D6]DMSO): δ = 2.91–2.29 (1H, m), 3.13–3.30 (2H, m), 5.89 (1H, s), 6.86 (1H, d,
J = 7.9 Hz), 7.08 (1H, t, J = 7.4 Hz), 7.17–7.30 (3H, m), 7.48 (1H, d, J = 5.3 Hz), 7.53 (1H,s), 8.07 (1H, d, J
= 5.3 Hz), 8.81 (1H, s), and 11.86 (1H, s); 13C-NMR (100 MHz, [D6]DMSO): δ = 33.8, 34.3, 49.0, 50.1,
50.8, 58.2, 114.6, 126.7, 126.9, 128.6, 128.9, 129.4, 129.7, 130.3, 130.5, 131.0, 134.2, 135.4, 138.2, and 142.6.
The analysis calculated for C17H17N3 was C: 77.54, H: 6.51, and N: 15.96; found values were C: 77.56,
H: 6.50, and N: 15.94.
3.2.13. Synthesis of 3-(1,2,3,4-Tetrahydroisoquinolin-1-yl)-5-azaindole
Product 20 (Figures S25 and S26) was purified by column chromatography (DCM/MeOH 9:1)
and crystallized from n-hexane. It was a light beige solid, with mp: 118–119 ◦C; yield: 72% (46
mg); 1H-NMR (500 MHz, ([D6]DMSO): δ = 2.88–3.39 (4H, m), 6.35 (1H, s), 6.92 (1H, d, J = 7.8 Hz),
7.27–7.49(3H, m), 7.80–7.92 (1H, m), 8.03 (1H, d, J = 7.1 Hz), 8.45 (1H, d, J = 7.1 Hz), 9.14(1H, s),
and 13.25 (1H, s); 13C-NMR (100 MHz, [D6]DMSO): δ = 29.7, 42.3, 54.1, 107.3, 118.8, 123.5, 125.8, 125.9,
126.4, 127.6, 129.3, 135.6, 139.3, 140.3, 140.5, and 143.6. The analysis calculated for C16H15N3 was C:
77.08, H: 6.06, and N: 16.85; found values were C: 77.02, H: 5.98, and N: 16.88.
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3.2.14. Synthesis of 3-(1,2,3,4-Tetrahydro-β-carboline-1-yl)-5-azaindole
Product 22 (Figures S27 and S28) was purified by column chromatography (DCM/MeOH 3:1)
and crystallized from n-hexane. It was a light brown solid, with mp: 187–189 ◦C; yield: 69% (50
mg); 1H-NMR (500 MHz, ([D6]DMSO): δ = 2.75–2.82 (1H, m), 2.84–2.91 (1H, m), 3.07–3.13 (1H, m),
3.22–3.27 (1H, m), 5.63 (1H, s), 6.97–7.03 (2H, m), 7.18 (1H, d, J = 6.6 Hz), 7.32–7.38 (2H, m), 7.47 (1H, d,
J = 5.4 Hz), 8.11 (1H, d, J = 4.5 Hz), 8.49 (1H, s,), 10.53 (1H, s,), and 11.50 (1H, s); 13C-NMR (100 MHz,
[D6]DMSO): δ = 22.0, 42.1, 49.6, 107.3, 107.9, 111.6, 115.2, 118.1, 118.8, 121.3, 123.8, 126.6, 127.2, 135.0,
136.4, 140.3, 140.4, and 143.1. The analysis calculated for C18H16N4 was C: 74.98, H: 5.59, and N: 19.43;
found values were C: 74.93, H: 5.58, and N: 19.46.
3.2.15. Synthesis of 3-(4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-4-yl)-5-azaindole
Product 23 (Figures S29 and S30) was purified by column chromatography (DCM/MeOH 9:1)
and crystallized from n-hexane. It was a light beige solid, with mp: 113–115 ◦C; yield: 80% (52 mg);
1H-NMR ([D6]DMSO): δ = 2.80–3.23 (4H, m), 5.26 (1H, s), 6.48 (1H, d, J = 5.1 Hz), 6.98–7.40 (3H, m),
8.08 (1H, d, J = 5.5 Hz), 8.16 (1H, s), and 11.24 (1H, s); 13C-NMR ([D6]DMSO): δ = 25.8, 42.4, 52.0,
107.3, 117.7, 122.4, 123.6, 125.3, 126.7, 134.4, 137.9, 140.3, 140.4, and 143.3. The analysis calculated for
C14H13N3S was C: 65.85, H: 5.13, and N: 16.46; found values were C: 65.84, H: 5.14, and N: 16.49.
3.2.16. Synthesis of 3-(2,3,4,5-Tetrahydro-1H-benzo[c]azepin-1-yl)-5-azaindole
Product 24 (Figures S31 and S32) was purified by column chromatography (DCM/MeOH 9:1)
and crystallized from n-hexane. It was a light beige solid, with mp: 142–145 ◦C; yield: 65% (43 mg);
1H-NMR ([D6]DMSO): δ = 2.82–3.09 (6H, m), 5.40 (1H, s), 6.81 (1H, d, J = 6.7 Hz), 6.93–7.02 (1H, m),
7.07–7.14 (3H, m), 7.19 (1H, d, J = 7.3 Hz), 7.35 (1H, d, J = 7.3 Hz), 8.12 (1H, d, J = 5.7 Hz), 8.72 (1H,
s), 11.27 (1H, brs); 13C-NMR (CDCl3): δ = 30.2, 35.8, 53.4, 106.8, 117.8, 123.6, 124.3, 126.1, 127.2, 127.7,
129.3, 130.0, 140.3, 140.7, 142.2, 143.2, and 144.0. The analysis calculated for C17H17N3 was C: 77.54, H:
6.51, and N: 15.96; found values were C: 77.57, H: 6.52, and N: 15.94.
4. Conclusions
To conclude, the modified aza-Friedel–Crafts reaction was applied for the C-3
substitution of azaindoles. The reactions were achieved by using 3,4-dihydroisoquinoline;
6,7-dihydrothieno[3,2-c]pyridine; 3,4-dihydro-β-carboline; and 4,5-dihydro-3H-benz[c]azepine as imine
substrates. The reactions of 4-azaindole and 6-azaindole with similar reactivity led to the formation
of new 3-isoquinolyl-, 3-thieno[3,2-c]pyridyl-, 3-β-carbolinyl-, and 3-benz[c]azepinyl-azaindole
derivatives. Starting from 5-azaindole, the modified aza-Friedel–Crafts reaction could only be
performed by using 10 mol % of p-TSA as a catalyst. Systematic correlation was found between the
reactivity of azaindoles and their pKa values. This latter observation allows us to explain why the
direct coupling of 5-azaindole works only under acidic conditions. Namely, 5-azaindole (pKa = 8.42)
has the highest basicity in the series of 4-, 5-, 6-, and 7-azaindoles. It is important to note that all
reactions could be accelerated by using microwave irradiation.
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